Fatty acid conjugated EPI-X4 derivatives with increased activity and in vivo stability

Mirja Harms1, André Haase2, Armando Rodríguez-Alfonso3

  • 1Institute of Molecular Virology, Ulm University Medical Center, Ulm 89081, Germany.

Insights

Optimized EPI-X4 peptide variants with fatty acids show enhanced CXCR4 antagonism and stability. These lipopeptides demonstrate therapeutic potential for diseases involving the CXCL12/CXCR4 axis.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • The CXCL12/CXCR4 signaling pathway is crucial in various diseases, including cancer and autoimmune disorders.
  • CXCR4 is a key therapeutic target due to its role in disease pathogenesis.
  • Existing CXCR4 antagonists face challenges in stability and potency.

Purpose of the Study:

  • To optimize the endogenous CXCR4 antagonist EPI-X4 for improved stability and efficacy.
  • To investigate the structure-activity relationships of EPI-X4 derivatives.
  • To explore the therapeutic potential of modified EPI-X4 in disease models.

Main Methods:

  • Structure-activity relationship studies involving conjugation of EPI-X4 with fatty acids.
  • Molecular dynamic simulations to analyze peptide-receptor interactions.
  • In vitro and in ovo assays using human retinoblastoma cells.
  • In vivo pharmacokinetic studies assessing plasma stability and circulation time.

Main Results:

  • Lipidation of EPI-X4 derivatives enhanced receptor affinity and antagonistic activity.
  • Molecular simulations showed lipid moieties stabilize interactions within the CXCR4 binding pocket.
  • Lipidated EPI-X4 exhibited increased stability in human plasma and prolonged circulation.
  • Selected candidates demonstrated significant therapeutic efficacy in retinoblastoma models.

Conclusions:

  • Fatty acid conjugation is an effective strategy to enhance the stability and efficacy of EPI-X4.
  • Lipidated EPI-X4 derivatives show promise as therapeutic agents targeting the CXCR4 pathway.
  • The findings highlight the importance of optimizing peptide stability for clinical translation.

Related Concept Videos

Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.3K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.7K
Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.6K